Analysts say there will be greater uncertainty about revenue from favipiravir due to companies going for a pricing war
from Livemint - Companies https://ift.tt/30VmrgI
https://ift.tt/eA8V8J
Thursday, August 13, 2020
Covid drugs rescue earnings of pharma companies in Q1
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment